DISCLOSEDQuarterlyRenaissance TechnologiesInmune Bio Inc · NASDAQ17,000 sh · $19.2KFiled 31 Mar 2026·SEC 13F·view source
DISCLOSEDStaleBlackRockInmune Bio Inc · NASDAQ812,895 sh · $7.2MFiled 30 Jun 2024·SEC 13F·view source